Phenylketonuria Drugs Market Size

Phenylketonuria Treatment Market size was valued at USD 794.16 million in 2024 and is set to exceed USD 1.98 billion by 2037, expanding at over 7.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of phenylketonuria treatment is evaluated at USD 843.44 million.

The growth of the market can be attributed to the rising prevalence of phenylketonuria globally and high incidence rate of the disorder in some emerging countries such as Turkey. Further, the increasing government initiatives in order to increase awareness & knowledge towards market, along with the surge in the mergers and acquisitions between different key players for the development of new drugs is propelling demand for phenylketonuria treatment are anticipated to drive the market growth. Moreover, rising research activities in the field of biotechnology and genomics is also anticipated to contribute to the growth of the market in the coming years.